Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Common Equity (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of Common Equity data on record, last reported at $51.2 million in Q3 2025.

  • For Q3 2025, Common Equity fell 5.43% year-over-year to $51.2 million; the TTM value through Sep 2025 reached $51.2 million, down 5.43%, while the annual FY2024 figure was $55.8 million, 14.3% up from the prior year.
  • Common Equity reached $51.2 million in Q3 2025 per SRTS's latest filing, down from $52.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $55.8 million in Q4 2024 and bottomed at $20.2 million in Q2 2021.
  • Average Common Equity over 5 years is $43.5 million, with a median of $47.1 million recorded in 2022.
  • Peak YoY movement for Common Equity: fell 16.82% in 2021, then soared 128.68% in 2022.
  • A 5-year view of Common Equity shows it stood at $26.0 million in 2021, then surged by 84.77% to $48.1 million in 2022, then increased by 1.61% to $48.8 million in 2023, then increased by 14.3% to $55.8 million in 2024, then dropped by 8.3% to $51.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $51.2 million in Q3 2025, $52.1 million in Q2 2025, and $53.0 million in Q1 2025.